FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 113 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,619,026 | +772.9% | 171,507 | +163.5% | 0.01% | +800.0% |
| Q1 2023 | $185,467 | -17.0% | 65,076 | +112.0% | 0.00% | 0.0% |
| Q4 2022 | $223,511 | -24.5% | 30,702 | -16.0% | 0.00% | -50.0% |
| Q3 2022 | $296,000 | -76.1% | 36,541 | -85.6% | 0.00% | -75.0% |
| Q2 2022 | $1,240,000 | +382.5% | 253,054 | +2224.4% | 0.01% | +300.0% |
| Q1 2022 | $257,000 | -41.7% | 10,887 | -56.3% | 0.00% | -50.0% |
| Q4 2021 | $441,000 | -48.7% | 24,924 | -18.3% | 0.00% | -63.6% |
| Q3 2021 | $860,000 | +2865.5% | 30,498 | +991.2% | 0.01% | – |
| Q2 2021 | $29,000 | -32.6% | 2,795 | -23.5% | 0.00% | -100.0% |
| Q1 2021 | $43,000 | +616.7% | 3,655 | +570.6% | 0.00% | – |
| Q4 2020 | $6,000 | +50.0% | 545 | +172.5% | 0.00% | – |
| Q2 2020 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $70,091,000 | 17.54% |
| TRV GP IV, LLC | 2,343,154 | $41,450,000 | 11.92% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $3,538,000 | 1.49% |
| HighVista Strategies LLC | 89,963 | $1,591,000 | 1.27% |
| Logos Global Management LP | 685,000 | $12,118,000 | 1.25% |
| Monashee Investment Management LLC | 273,045 | $4,830,000 | 1.19% |
| RTW INVESTMENTS, LP | 3,866,872 | $68,405,000 | 1.00% |
| Parkman Healthcare Partners LLC | 250,106 | $4,424,000 | 0.98% |
| Deep Track Capital, LP | 750,000 | $13,268,000 | 0.94% |
| Darwin Global Management, Ltd. | 317,428 | $5,615,000 | 0.86% |